EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieKlinische Studie (Phase III)

Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia

Martin Schrappe, Franco Locatelli, Maria Grazia Valsecchi, Gerhard Zugmaier, Michaela Vossen-Gajcy, Jan Starý, Andishe Attarbaschi iD, Anja Möricke, Jean-Pierre Bourquin, Draga Barbaric, Sarah Elitzur, Daniela Silvestri und 29 weitere

New England Journal of Medicine · 17.09.2026 · 395 (11) · 1075-1089

DOI: 10.1056/nejmoa2604166 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 17.09.2026. Verfasst von Martin Schrappe und 40 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics I, Pediatric Hematology and Oncology, ALL-Berlin-Frankfurt-Münster Study Group, Christian Albrechts University Kiel and Univ…. Hauptthemen laut MEDLINE: Antibodies, Bispecific, Antineoplastic Agents, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Deutsche Krebshilfe, Fondazione Maria Letizia Verga and Fondazione Tettamanti, Monza.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, BispecificAntineoplastic AgentsPrecursor B-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaAdolescentChildChild, PreschoolFemaleHumansInfantMaleAntigens, CD19Antineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalIntention to Treat AnalysisKaplan-Meier EstimateConsolidation ChemotherapyFollow-Up StudiesInfectionsCytokine Release Syndrome

Substanzen

Antibodies, BispecificAntigens, CD19Antineoplastic Agentsblinatumomab

Autor:innen und Institutionen

  • Department of Pediatrics I, Pediatric Hematology and Oncology, ALL-Berlin-Frankfurt-Münster Study Group, Christian Albrechts University Kiel and University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Department of Pediatric Hematology and Oncology, IRCCS Ospedale Bambino Gesù, Rome.
  • Catholic University of the Sacred Heart, Rome.
  • School of Medicine and Surgery, University of Milan-Bicocca, Milan.
  • Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
  • Amgen Research, Munich, Munich, Germany.

ORCID-Profile: Andishe Attarbaschi

Förderung

  • Ministerstvo Zdravotnictví Ceské Republiky
  • Deutsche Krebshilfe
  • Fondazione Maria Letizia Verga and Fondazione Tettamanti, Monza
  • Fondazione Città della Speranza
  • Ministry of Health of the Czech Republic
  • Israel Cancer Association and the Chaim Association
  • Deutsche Krebshilfe, Bonn, Germany
  • Motol University Hospital, Prague, Czech Republic

Zitieren

APA

Schrappe, M., Locatelli, F., Valsecchi, M. G., Zugmaier, G., Vossen-Gajcy, M., Starý, J., Attarbaschi, A., Möricke, A., Bourquin, J. P., Barbaric, D., Elitzur, S., Silvestri, D., Kolenova, A., Dalla-Pozza, L., Bodmer, N., Stanulla, M., Alten, J., Zaman, F., Bergmann, A., …, & AIEOP-BFM ALL 2017 Consortium (2026). Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia. New England Journal of Medicine, 395(11), 1075-1089. https://doi.org/10.1056/nejmoa2604166

Vancouver

Schrappe M, Locatelli F, Valsecchi MG, Zugmaier G, Vossen-Gajcy M, Starý J, et al. Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia. New England Journal of Medicine. 2026;395(11):1075-1089. doi:10.1056/nejmoa2604166

BibTeX
@article{Schrappe2026,
  author = {Schrappe, Martin and Locatelli, Franco and Valsecchi, Maria Grazia and Zugmaier, Gerhard and Vossen-Gajcy, Michaela and Starý, Jan and Attarbaschi, Andishe and Möricke, Anja and Bourquin, Jean-Pierre and Barbaric, Draga and Elitzur, Sarah and Silvestri, Daniela and Kolenova, Alexandra and Dalla-Pozza, Luciano and Bodmer, Nicole and Stanulla, Martin and Alten, Julia and Zaman, Faraz and Bergmann, Anke and Cazzaniga, Giovanni and Brüggemann, Monika and Buldini, Barbara and Köhler, Rolf and Fazio, Grazia and Rössig, Claudia and Sramkova, Lucie and Parasole, Rosanna and Hundsdörfer, Patrick and Putti, Maria Caterina and Borkhardt, Arndt and Fagioli, Franca and Bettini, Laura Rachele and Poyer, Fiona and von Stackelberg, Arend and Vinti, Luciana and Conter, Valentino and Zimmermann, Martin and Rizzari, Carmelo and Cario, Gunnar and Biondi, Andrea and AIEOP-BFM ALL 2017 Consortium, AIEOP-BFM ALL 2017 Consortium},
  title = {Blinatumomab for Replacing Chemotherapy in Pediatric Acute Lymphoblastic Leukemia},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {395},
  number = {11},
  pages = {1075--1089},
  doi = {10.1056/nejmoa2604166}
}
Kostenlos starten →